Type II PSG for ENT: Pre-Operative Sleep Apnea Diagnostics
For the Otolaryngologist, a standard AHI score is often insufficient for surgical planning. Effective intervention—whether it involves septoplasty, UPPP, or hypoglossal nerve stimulation—requires a granular understanding of respiratory effort and sleep architecture. DormoVision X™ provides a high-fidelity, 38-channel Type II polysomnography solution that delivers in-lab precision in a home-based format. By capturing EEG-validated sleep stages alongside multi-band respiratory signals, ENT specialists can accurately phenotype patients and ensure surgical outcomes are backed by gold-standard evidence.
Key Benefits
Comprehensive Upper Airway Phenotyping: Go beyond basic airflow monitoring. DormoVision X™ utilizes dual-band respiratory effort sensors and high-resolution oximetry to provide a detailed view of inspiratory effort and paradoxical breathing. This data is critical for identifying the physiological drivers of obstruction and predicting the success of specific surgical interventions.
EEG-Validated Sleep Staging (6-Channel Suite): Identifying REM-related apnea is vital for surgical clearance. Unlike Level III tests that “estimate” sleep, our 6-channel EEG suite allows you to correlate obstructive events with specific sleep stages. This prevents the “under-diagnosis” of severe apnea that occurs only during REM, providing a complete picture of sleep fragmentation.
Nasal Patency Friendly, Wireless & Cannula-Free: Traditional nasal cannulas are often incompatible with patients suffering from severe septal deviation, nasal polyps, or valve collapse. DormoVision X™ features a wireless, mask-integrated design that eliminates the need for intranasal sensors, ensuring a comfortable and accurate study for patients with compromised nasal airways.
Clinically Validated Precision (0.97 Kappa Agreement): Trust your data as you would an in-lab study. With a 0.97 Cohen’s Kappa and 96.6% severity classification agreement compared to the Nox A1 gold standard, DormoVision X™ meets the rigorous diagnostic requirements for documenting medical necessity and securing surgical authorizations.
Features
- One Platform, Full PSG Capability At Home or In-Lab.
- Wireless, Remote, And FDA-Cleared.
- 38 Total Channels For Comprehensive Sleep Data.
- Faster Diagnoses with Greater Clinical Confidence.
- Expand Capacity, Reduce Costs, No Added Overhead.
- Patient-Friendly Solution for Diagnosing Complex Sleep Disorders in Children
Validated via NCT06224972 (N=47)
-
Nox A1 Comparison: Virtually identical mean AHI values recorded head-to-head.
-
Severity Match: Near-perfect alignment in distinguishing mild, moderate, and severe OSA cases.
-
Signal Reliability: Strong correlations across all secondary sleep parameters with minimal variance.